Advertisement
YOU ARE HERE: LAT HomeCollectionsVivorx Inc
IN THE NEWS

Vivorx Inc

FEATURED ARTICLES
BUSINESS
September 15, 1995 | Times Wire Services
Two drug companies have allied to sell an experimental diabetes treatment derived from seaweed that could reduce or eliminate the need for insulin injections. The treatment, which involves transplantation into the body of pancreas cells that produce insulin, was developed by Santa Monica-based VivoRx Inc. VivoRx gave the right to sell the treatment in North America to Mylan Laboratories Inc.
ARTICLES BY DATE
BUSINESS
September 15, 1995 | Times Wire Services
Two drug companies have allied to sell an experimental diabetes treatment derived from seaweed that could reduce or eliminate the need for insulin injections. The treatment, which involves transplantation into the body of pancreas cells that produce insulin, was developed by Santa Monica-based VivoRx Inc. VivoRx gave the right to sell the treatment in North America to Mylan Laboratories Inc.
Advertisement
BUSINESS
June 6, 1997 | MYRON LEVIN, TIMES STAFF WRITER
A multimillion-dollar fraud and racketeering suit filed in federal court in Los Angeles accuses an arbitration service and a group of lawyers and businessmen of an elaborate scheme to manufacture financial disputes and use their control over the arbitration service to extract money from adversaries. The 95-page complaint, filed this week by three Los Angeles-area landlords, claims the Southern California Arbitration Assn.
BUSINESS
April 24, 1995 | BARBARA MARSH, TIMES STAFF WRITER
Dr. David Scharp figures he just got the chance of a lifetime. For two decades, the noted St. Louis surgeon has been working on new treatments for diabetics. He joined Neocrin Inc. recently and found himself in the thick of a race to develop a new method for attacking diabetes. The small research firm is on the cutting edge of technology as it experiments with an implant that can act like a pancreas and eliminate the need for insulin injections. "This is the assault on the summit!"
BUSINESS
July 1, 2000 | MYRON LEVIN, TIMES STAFF WRITER
A Los Angeles Superior Court judge has entered a $5.1-million fraud and racketeering judgment stemming from an elaborate scheme to extract damages from unwary parties who were hauled before a fly-by-night arbitration service. The default judgment issued by Judge Anthony J. Mohr concludes the unusual case of the defunct Southern California Arbitration Assn.
BUSINESS
March 29, 1995 | BARBARA MARSH, TIMES STAFF WRITER
Dr. David Scharp figures he just got the chance of a lifetime. For two decades, the noted St. Louis surgeon has been working on new treatments for diabetics. He joined Neocrin Inc. recently and found himself in the thick of a race to develop a new method for attacking diabetes. The small research firm is on the cutting edge of technology as it experiments with an implant that can act like a pancreas and eliminate the need for insulin injections. "This is the assault on the summit!"
Los Angeles Times Articles
|